{1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (150000 MG) (urea 350 MG/ML Topical Foam) } Pack
- RxCUI
- 1247823
- RxNorm name
- {1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (150000 MG) (urea 350 MG/ML Topical Foam) } Pack
- Display name
- Salicylic acid/Urea (Pack)
- Full name
- {1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (150000 MG) (urea 350 MG/ML Topical Foam) } Pack
- Term type
- GPCK
- Status
- Active
- Strength
- mixed
- Dose form
- Pack
- Route
- Pack
- Updated
- 2026-07-19 06:53:13
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042012
- Active start
- 042012
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| urea | 350 MG / 1 ML | urea | urea |
| salicylic acid | 60 MG / 1 ML | salicylic acid | salicylic acid |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Pack | 746839 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| urea | 11002 |
| salicylic acid | 9525 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | {1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (150000 MG) (urea 350 MG/ML Topical Foam) } Pack | NAMES |
| RxNorm Name | {1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (150000 MG) (urea 350 MG/ML Topical Foam) } Pack | NAMES |
| TTY | GPCK | ATTRIBUTES |
| RxCUI | 1247823 | CODES |
| MMSL_CODE | CD27291 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | S01BC | Antiinflammatory agents, non-steroids | ATC1-4 | salicylic acid | |
| ATC | D02AE | Carbamide products | ATC1-4 | urea | |
| ATC | D01AE | Other antifungals for topical use | ATC1-4 | salicylic acid | |
| ATC | B05BC | Solutions producing osmotic diuresis | ATC1-4 | urea | |
| MEDRT | D020156 | Salicylic Acid | CHEM | has_ingredient | salicylic acid |
| MEDRT | D014508 | Urea | CHEM | has_ingredient | urea |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | salicylic acid |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | salicylic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | salicylic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | urea |
| MEDRT | D017488 | Hyperkeratosis, Epidermolytic | DISEASE | may_treat | urea |
| MEDRT | D019586 | Intracranial Hypertension | DISEASE | may_treat | urea |
| MEDRT | D017492 | Keratosis, Seborrheic | DISEASE | may_treat | salicylic acid |
| MEDRT | D009798 | Ocular Hypertension | DISEASE | may_treat | urea |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | salicylic acid |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | salicylic acid |
| MEDRT | D014860 | Warts | DISEASE | may_treat | salicylic acid |
| MEDRT | N0000000065 | Physiochemical Activity | MOA | has_moa | urea |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | salicylic acid |
| MEDRT | N0000009035 | Emollient Activity | PE | has_pe | urea |
| MEDRT | N0000010240 | Increased Renal Urea Excretion | PE | has_pe | urea |
| MEDRT | N0000009974 | Increased Skin Keratinization | PE | has_pe | salicylic acid |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | GPCK |
| CODES | MMSL_CODE | CD27291 |
| CODES | RxCUI | 1247823 |
| NAMES | Prescribable Synonym | salicylic acid 6 % Topical Foam (70 GM) / urea 35 % Topical Foam (150 GM) Pack |
| NAMES | RXNAV_STR | {1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (150000 MG) (urea 350 MG/ML Topical Foam) } Pack |
| NAMES | RxNorm Name | {1 (70000 MG) (salicylic acid 60 MG/ML Topical Foam) / 1 (150000 MG) (urea 350 MG/ML Topical Foam) } Pack |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |